In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in β-thalassemia/hemoglobin E patients-Reference-Cited by-同舟云学术

In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in β-thalassemia/hemoglobin E patients

Published:2005-12 Issue:12 Volume:33 Page:1486-1492
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Watanapokasin Yuwadee,Chuncharunee Suporn,Sanmund Duangmanee,Kongnium Wantana,Winichagoon Pranee,Rodgers Griffin P.,Fucharoen Suthat

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference29 articles.

1. Novel treatment options in the severe beta-globin disorders;Rodgers;Br J Haematol,1995

2. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the national Institutes of Health experience;Rodgers;Semin Oncol,1992

3. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in β-thalassemia/Hb E disease;Fucharoen;Blood,1996

4. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia;Charache;N Engl J Med,1995

5. Reactivation of fetal hemoglobin in patients with beta-thalassemia;Olivieri;Semin Hematol,1996

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive study of immune function and immunophenotyping of white blood cells from β‐thalassaemia/ HbE patients on hydroxyurea supports the safety of the drug;British Journal of Haematology;2022-10-11

2. Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective;Pharmaceuticals;2022-06-16

3. Revisiting fetal hemoglobin inducers in beta-hemoglobinopathies: a review of natural products, conventional and combinatorial therapies;Molecular Biology Reports;2021-11-25

4. Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia—Major Patients with the XmnI Polymorphism;Genetic Testing and Molecular Biomarkers;2021-08-01

5. Emerging therapies in β-thalassemia: toward a new era in management;Expert Opinion on Emerging Drugs;2020-04-02